RNAZ
USDTransCode Therapeutics Inc. Common Stock
$9.500-0.410 (-4.137%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$9.910
고가
$10.450
저가
$9.500
거래량
0.01M
기업 기본 정보
시가총액
8.7M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.14M
거래소
NCM
통화
USD
52주 범위
저가 $6.15현재가 $9.500고가 $494.34
관련 뉴스
PR Newswire
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
더 보기
PR Newswire
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
더 보기
